![William Martin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Martin
Direttore operativo presso EpiVax, Inc.
Posizioni attive di William Martin
Società | Posizione | Inizio | Fine |
---|---|---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Direttore operativo | 01/01/1998 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/1998 | - | |
Epivax Oncology, Inc.
![]() Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Direttore operativo | - | - | |
Direttore Tecnico/Scientifico/R&S | - | - |
Storia della carriera di William Martin
Precedenti posizioni note di William Martin
Società | Posizione | Inizio | Fine |
---|---|---|---|
Abt Associates, Inc.
![]() Abt Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Abt Associates, Inc. provides research and consulting services. It offers greenhouse gas emissions mitigation, low-emission development strategies, environmental research, air quality regulatory support, decision-support tools and IT solutions, ecological risk assessment, economic and regulatory analysis, value chain development, housing policies and programs, health systems strengthening, and workforce development. The company was founded by Clark Abt on January 12, 1965 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - | - |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 3 |
Commercial Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
PAREXEL International Corp.
![]() PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Abt Associates, Inc.
![]() Abt Associates, Inc. Miscellaneous Commercial ServicesCommercial Services Abt Associates, Inc. provides research and consulting services. It offers greenhouse gas emissions mitigation, low-emission development strategies, environmental research, air quality regulatory support, decision-support tools and IT solutions, ecological risk assessment, economic and regulatory analysis, value chain development, housing policies and programs, health systems strengthening, and workforce development. The company was founded by Clark Abt on January 12, 1965 and is headquartered in Cambridge, MA. | Commercial Services |
Epivax Oncology, Inc.
![]() Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- William Martin
- Esperienza